{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:27:25Z","timestamp":1780518445373,"version":"3.54.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background. \u2003Oral poliovirus vaccine (OPV) results in an ongoing burden of poliomyelitis due to vaccine-associated paralytic poliomyelitis and circulating vaccine-derived polioviruses (cVDPVs). This motivates globally coordinated OPV cessation after wild poliovirus eradication.<\/jats:p>\n               <jats:p>Methods. \u2003We modeled poliovirus transmission and OPV evolution to characterize the interaction between population immunity, OPV-related virus prevalence, and the emergence of cVDPVs after OPV cessation. We explored strategies to prevent and manage cVDPVs for countries that currently use OPV for immunization and characterized cVDPV emergence risks and OPV use for outbreak response.<\/jats:p>\n               <jats:p>Results. \u2003Continued intense supplemental immunization activities until OPV cessation represent the best strategy to prevent cVDPV emergence after OPV cessation in areas with insufficient routine immunization coverage. Policy makers must actively manage population immunity before OPV cessation to prevent cVDPVs and aggressively respond if prevention fails. Sufficiently aggressive response with OPV to interrupt transmission of the cVDPV outbreak virus will lead to die-out of OPV-related viruses used for response in the outbreak population. Further analyses should consider the risk of exportation to other populations of the outbreak virus and any OPV used for outbreak response.<\/jats:p>\n               <jats:p>Conclusions. \u2003OPV cessation can successfully eliminate all circulating live polioviruses in a population. The polio end game requires active risk management.<\/jats:p>","DOI":"10.1093\/infdis\/jit845","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T12:59:57Z","timestamp":1413291597000},"page":"S475-S484","source":"Crossref","is-referenced-by-count":81,"title":["Modeling the Dynamics of Oral Poliovirus Vaccine Cessation"],"prefix":"10.1093","volume":"210","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"2023101210302804700_JIT845C1","volume-title":"Global eradication of poliomyelitis by the year 2000 (resolution 41.28)","author":"World Health Assembly","year":"1988"},{"key":"2023101210302804700_JIT845C2","first-page":"95","article-title":"Transmission of wild poliovirus type 2\u2014apparent global interruption","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"2023101210302804700_JIT845C3","article-title":"Global Polio Eradication Initiative: list of wild poliovirus by country","author":"World Health Organization"},{"key":"2023101210302804700_JIT845C4","volume-title":"Poliomyelitis: intensification of the global eradication initiative (resolution 65.5)","author":"World Health Assembly","year":"2012"},{"key":"2023101210302804700_JIT845C5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Review: oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of possible future global policies for managing polioviruses","volume":"98","author":"Thompson","year":"2008","journal-title":"Am J Public Health"},{"key":"2023101210302804700_JIT845C8","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"Medscape J Med"},{"key":"2023101210302804700_JIT845C9","volume-title":"Poliomyelitis: mechanism for management of potential risks to eradication (resolution 61.1)","author":"World Health Assembly","year":"2008"},{"key":"2023101210302804700_JIT845C10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","article-title":"Modeling population immunity to support efforts to end the transmission of live polioviruses","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1539-6924.2006.00843.x","article-title":"Evaluation of response scenarios to potential polio outbreaks using mathematical models","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for OPV cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"2023101210302804700_JIT845C13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/risa.12030","article-title":"Modeling poliovirus risks and the legacy of polio eradication","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"issue":"suppl 1","key":"2023101210302804700_JIT845C14","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1093\/infdis\/jit838","article-title":"Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation","volume":"210","author":"Duintjer Tebbens","year":"2014","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"2023101210302804700_JIT845C15","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jit834","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"2023101210302804700_JIT845C16","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1093\/infdis\/jit844","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"2023101210302804700_JIT845C17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/risa.12044","article-title":"Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2334-14-45","article-title":"The potential impact of expanding target age groups for polio immunization campaigns","volume":"14","author":"Duintjer Tebbens","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2023101210302804700_JIT845C19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178324","article-title":"On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations","volume":"28","author":"Diekmann","year":"1990","journal-title":"J Math Biol"},{"key":"2023101210302804700_JIT845C20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/risa.12031","article-title":"Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"2023101210302804700_JIT845C22","volume-title":"Global Polio Eradication Initiative: polio eradication and endgame strategic plan (2013\u20132018)","author":"World Health Organization","year":"2013"},{"key":"2023101210302804700_JIT845C23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2014.864563","article-title":"National policy choices related to inactivated poliovirus vaccine, innovation and the end game of polio global eradication","volume":"13","author":"Thompson","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2023101210302804700_JIT845C24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/risa.12019","article-title":"Pre-eradication vaccine policy options for poliovirus infection and disease control","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/210\/suppl_1\/S475\/52031144\/jid_210_suppl1_s475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/210\/suppl_1\/S475\/52031144\/jid_210_suppl1_s475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:30:51Z","timestamp":1697106651000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/210\/suppl_1\/S475\/2194317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":24,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jit845","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,11,1]]}}}